Cycle 2 – Module 7 – Lecture 1 – Hypercholesterolemia: The efficacy of Hormone therapies (2h25)

Abstract:

This instructive and information-rich video lecture offers new insight and solutions in the treatment of cholesterol disorders by correcting hormone deficiencies with hormone supplements. In many cases as good or sometimes better than statins.

Thyroid therapy may, for example, reduce serum levels of total and LDL cholesterol up to 40-50%, in particularly combinations that contain both T4 and T3, such as desiccated thyroid. Estrogen supplementation in women, testosterone supplementation in men, and growth hormone injections in men and women may reduce 10-20% cholesterol levels. Melatonin treatment has shown to reduce most types of hypercholesterolemia (medication-induced, familial, diet-induced, etc.), although often at supraphysiological doses in animals and humans.

Most of these hormone supplements also have beneficial effects to increase HDL cholesterol, and reduce the levels of oxidized LDL cholesterol.

The observational studies and randomized controlled trials showing all these links and the efficacy of hormone therapies in the various possible cholesterol disorders are shown and practical tips to apply in practice are provided.

 

The content is a video of 2h25, a PDF presentation file, a PDF references

• The 8 hormone therapies that reduce cholesterol disorders (high serum total, LDL, oxidized LDL, low HDL cholesterol) the best
  • Thyroid
  • Estrogens, progesterone
  • Testosterone
  • GH (growth hormone)
  • IGF-1
  • Melatonin
  • DHEA
• The scientific studies
• Practical tips, doses
• A PDF list of scientific studies showing associations between low hormone levels and the various cholesterol disorders is provided
• An abundant list of trials where hormone treatments reduce cholesterol disorders is provided

 

Educational outcome:

Transmission of knowledge on which hormone deficiencies may facilitate or even cause serum cholesterol disorders, and how hormone supplementations may reduce these disorders.

 

Learning outcomes:

• The physician should have learned to detect the hormone deficit(s) that cause or aggravate cholesterol disorders in patients.
• The physician should have learned to differentiate clinically (symptomatically) which hormone deficiency is behind a cholesterol disorder by knowing more about other somatic effect of these hormones.
• The physician should have learned to treat the hormone deficiency and even be able to finetune the doses to the needs and degree of cholesterol disorder of his or her patients.
• The physician should have learned more about the scientific studies that support this information, including double-blind placebo-controlled trials.

This course includes 1 video, 1 PDF presentation, 1 PDF with references, and 1 quiz.

For more information or inquiries, please contact us at medschool@hertoghe.eu